GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (NYSE:GMRE) » Definitions » Change In Receivables

Global Medical REIT (Global Medical REIT) Change In Receivables : $-1.2 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Global Medical REIT Change In Receivables?

Global Medical REIT's change in receivables for the quarter that ended in Mar. 2024 was $-1.0 Mil. It means Global Medical REIT's Accounts Receivable increased by $1.0 Mil from Dec. 2023 to Mar. 2024 .

Global Medical REIT's change in receivables for the fiscal year that ended in Dec. 2023 was $0.4 Mil. It means Global Medical REIT's Accounts Receivable declined by $0.4 Mil from Dec. 2022 to Dec. 2023 .

Global Medical REIT's Accounts Receivable for the quarter that ended in Mar. 2024 was $7.7 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Global Medical REIT's Days Sales Outstanding for the three months ended in Mar. 2024 was 20.15.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Global Medical REIT's liquidation value for the three months ended in Mar. 2024 was $-659.3 Mil.


Global Medical REIT Change In Receivables Historical Data

The historical data trend for Global Medical REIT's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Medical REIT Change In Receivables Chart

Global Medical REIT Annual Data
Trend Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.14 -1.60 -0.66 -2.97 0.43

Global Medical REIT Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.02 -0.15 -0.09 -0.98

Global Medical REIT Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Medical REIT  (NYSE:GMRE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Global Medical REIT's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=7.743/35.069*91
=20.15

2. In Ben Graham's calculation of liquidation value, Global Medical REIT's accounts receivable are only considered to be worth 75% of book value:

Global Medical REIT's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1.333-666.482+0.75 * 7.743+0.5 * 0
=-659.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Medical REIT Change In Receivables Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Medical REIT (Global Medical REIT) Business Description

Traded in Other Exchanges
Address
7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814
Global Medical REIT Inc is a Maryland corporation engaged primarily in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to strong healthcare systems and physician groups. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases. Its tenants are physician groups, regional or national healthcare systems or combinations thereof. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation.
Executives
Moore Roscoe M Jr director C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244
Henry Cole director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Jeffrey Busch director, officer: Chairman, President and CEO 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Lori Wittman director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Matthew Cypher director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Paula Crowley director 2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814
Ronald Marston director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Robert J Kiernan officer: Chief Financial Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Alfonzo Leon officer: Chief Investment Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Danica Holley officer: Chief Operating Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Jamie Allen Barber officer: Secretary and General Counsel 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Allen Webb officer: SVP 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Huiqi Zhang director, 10 percent owner 40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000
Notable Reward Ltd 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110
Superior Glory Enterprises Ltd. 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110